Scor’s $1bn US life liabilities retro arbitration with Covéa prompts analyst concerns
Uncertainty over the outcome of an arbitration dispute between Scor and Covéa over a US life liabilities quota share retrocession contract agreed in 2021 has prompted further analyst scrutiny amid ongoing concerns around the reinsurer’s life and health operations.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below